Clozaril
Introduced in Europe in 1975 by the Novartis Pharmaceuticals Corporation, clozaril was one of the first new drugs developed to treat schizophrenia in over 20 years. The pharmaceutical, which helps keep hallucinations, delusions, and hostility under control, did not enter the United States market until 14 years later and continues to be most heavily utilized in the Eastern Hemisphere.
Sorry, this page is not
available in your country.